This article explores best practices for modernizing the healthcare supply chain by balancing fiscal responsibility with patient safety requirements. It highlights how advanced technologies such as real-time AI monitoring and automated inventory systems help organizations navigate regulatory complexities while preventing product shortages.
This eBook explores Werner Enterprises' specialized logistics for high-stakes industries like healthcare, pharmaceuticals and high-end technology. It details how the company ensures the security and integrity of sensitive shipments through real-time tracking, rigorous driver training and advanced temperature control.
In this article, we explore how cold-chain logistics are evolving to support the unique demands of the pharmaceutical industry. From precision temperature control and proactive compliance management to real-time visibility and mission-critical support systems, discover the strategies that help ensure safe, reliable delivery of temperature-sensitive medicines. Featuring insights into emerging expectations for traceability, rapid response protocols, and customized logistics solutions, this piece highlights how best-in-class cold-chain practices build resilience and protect product integrity.
This case study leverages IQVIA data and analytics to explore how one pharmaceutical brand navigated mature lifecycle stages in a competitive class, implementing seamless prior auth strategies with CoverMyMeds where a 22 percentage point claim approval rate lift was observed, on average, helping mitigate decreasing access.
Discover three strategies for overcoming high costs, prior authorization delays and rejected claims.
The Drug Supply Chain Security Act (DSCSA) serialization mandate is now in full effect. Every pharmaceutical distributor and 3PL must trace serialized product at the unit level and stay in sync with trading partners in real time. There are multiple ways to meet the minimum requirements — but only one approach delivers full compliance without operational disruption. Tecsys provides that solution: the most complete, warehouse-native serialization capability, built directly into core workflows so compliance happens automatically as you work.
DSCSA compliance is only the beginning. Is your warehouse ready for the challenges it brings? Without the right strategies in place, compliance can create bottlenecks, delay shipments, and lead to costly disruptions. But with the right approach, it’s an opportunity to optimize your warehouse for long-term success. This playbook helps you turn compliance into a competitive edge. By adopting best practices beyond serialization and traceability, you can safeguard your operations, protect your reputation, and enhance patient safety.
Discover essential guidelines for complying with the Drug Supply Chain Security Act (DSCSA). Learn how to enhance supply chain security and meet regulatory standards across various roles in the pharmaceutical industry.
Surescripts streamlines the patient benefits verification process for life sciences companies with a single direct connection
This case study explores how one pharmaceutical brand responded to a significant formulary loss, implementing seamless provider prior authorization strategies through CoverMyMeds to mitigate impact and maintain market share in a highly competitive class.
This eBook, From Prescribing to Pick Up: Navigating the Access & Affordability Landscape, provides a focused view into CoverMyMeds’ access and affordability solutions and how they help biopharma brands overcome patient barriers. It highlights their integrated network, innovative technology, and human support services — including prior authorization solutions, hub services, and copay assistance — designed to streamline the patient journey, improve speed to therapy, and enhance health outcomes.
Discover how to evaluate the true costs and considerations of internal vs. outsourced sample storage.
See how one lab avoided $12 million research loss during an unplanned power and equipment failure.
Based on insights from over 360 life science professionals, this benchmark study examines how organizations across pharma, biotech, research, and healthcare are managing the storage and oversight of biological materials. The report reveals how leaders are balancing security, regulatory compliance, temperature control, and cost while maintaining the speed and reliability required for critical sample access.
Point of Care and PatientPoint can improve the impact that your Pharma Reps are already having.
Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.
This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.
Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.
Imagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. Join Marken’s patient centric solutions expert and our featured guest for a dynamic discussion on how customizable site augmentation programs are accelerating life-saving treatments to market faster through scalable, flexible decentralized strategies. Learn practical solutions for streamlining on-site, remote or hybrid trials by matching dedicated clinical research professionals to your site’s unique needs, relieving staff burdens and empowering your team to focus on what matters most – patient care.
Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss that required continuous -80°C temperature control and dry ice replenishment throughout an 80-hour transit – Marken activated a customized, precision-driven supply chain strategy. Navigating one of the world’s most complex regulatory landscapes for advanced therapies, success depended on flawless execution, specialized handling protocols, and seamless cross-functional collaboration. So how did Marken overcome these high-stakes challenges – ensuring the integrity of these transformative therapeutics while exceeding client expectations? Read the full case study to find out.
When a South Korean patient needed a life-changing gene therapy, Marken orchestrated an international distribution strategy under the strictest regulatory and temperature specifications. With precise temperature-control required at -80°C with dry ice, Marken’s teams navigated weekend scheduling, specialized package handling and final-mile complexities to ensure the vital treatment remained on schedule with white glove service from pick up to final mile delivery. Discover how Marken made it happen.